Intuitive Surgical (NASDAQ:ISRG) Stock Price Expected to Rise, Leerink Partners Analyst Says
Intuitive Surgical (NASDAQ:ISRG – Get Free Report) had its target price hoisted by equities researchers at Leerink Partners ...
Leerink Partnrs Has Bearish Forecast for BBIO Q4 Earnings
Research analysts at Leerink Partnrs reduced their Q4 2024 earnings per share (EPS) estimates for shares of BridgeBio Pharma ...
Vincerx Pharma enters at-the-market equity offering deal
Vincerx Pharma, Inc. (NASDAQ:VINC), a pharmaceutical company, announced today an agreement with H.C. Wainwright & Co., LLC to sell up to $30 million of its common stock in an at-the-market equity ...
Leerink Partners Remains a Buy on AnaptysBio (ANAB)
In a report released on January 16, David Risinger from Leerink Partners maintained a Buy rating on AnaptysBio (ANAB – Research Report). The ...
Investing16d
Leerink raises Progyny stock target, market perform rating on resilience
On Monday, Progyny (NASDAQ:PGNY) shares saw a change in their market prospects as Leerink Partners adjusted the company's price target. Analysts at Leerink Partners increased the price target on ...
Investing16d
Leerink cuts 4D Molecular Therapeutics price target following pipeline updates
On Monday, Leerink Partners adjusted its price target for 4D Molecular Therapeutics (NASDAQ:FDMT) shares, lowering it to $27 from the previous $31 while maintaining an Outperform rating. The revision ...